Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | AAPG | CLDX | ||
| Company | Provention Bio Inc | Ascentage Pharma Group Intl ADR | Celldex Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.99 | 26.72 | 34.39 | ||
| High | 25.00 | 26.72 | 34.39 | ||
| Low | 24.98 | 25.60 | 33.64 | ||
| Latest | 24.98 | 25.65 | 34.25 | ||
| Change | +0.75 | -0.71 | -0.13 | ||
| % Change | +3.10% | -2.69% | -0.38% | ||
| Volume | 9,124,100 | 4,700 | 797,900 | ||
| 20-Day Average Volume | 2,505,925 | 3,075 | 1,227,395 | ||
| Previous Close | 24.23 | 26.36 | 34.38 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 25.35 | 32.31 | ||
| 20-Day Raw Stochastic | 98.15% | 65.06% | 79.13% | ||
| 20-Day Relative Strength | 79.66 | 51.45 | 62.58 | ||
| Weighted Alpha | +19.60 | -11.73 | +59.23 | ||
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | -0.16% since 04/14/26 | +2.76% since 04/14/26 | ||
| Low | 24.20 on 04/25/23 | 25.60 on 04/21/26 | 33.28 on 04/16/26 | ||
| High | 25.00 on 04/26/23 | 27.40 on 04/17/26 | 35.79 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | +34.22% since 03/20/26 | +10.84% since 03/20/26 | ||
| Low | 23.82 on 03/27/23 | 21.16 on 03/23/26 | 28.41 on 04/02/26 | ||
| High | 25.00 on 04/26/23 | 28.06 on 04/06/26 | 35.79 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | -2.80% since 01/21/26 | +30.88% since 01/21/26 | ||
| Low | 6.59 on 03/10/23 | 19.11 on 03/20/26 | 22.33 on 02/06/26 | ||
| High | 25.00 on 04/26/23 | 28.06 on 04/06/26 | 35.79 on 04/20/26 | ||
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | -25.57% since 10/21/25 | +22.72% since 10/21/25 | ||
| Low | 6.38 on 10/28/22 | 19.11 on 03/20/26 | 22.10 on 11/11/25 | ||
| High | 25.00 on 04/26/23 | 35.49 on 10/22/25 | 35.79 on 04/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 2,460,205 | 2,288,539 | ||
| Shares Outstanding, K | 94,781 | 93,331 | 66,566 | ||
| Annual Sales | 12,900,000 | 82,100,000 | 1,550,000 | ||
| Annual Net Income | -113,570,000 | -177,710,000 | -258,760,000 | ||
| Last Quarter Sales | 10,810,000 | N/A | 120,000 | ||
| Last Quarter Net Income | -33,280,000 | N/A | -81,320,000 | ||
| 60-Month Beta | 2.47 | 0.79 | 1.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | N/A | -1.22 on 02/25/26 | ||
| Latest Earnings Date | 05/04/23 | 03/25/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||